CounterPath Reports Second Quarter Fiscal 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Counterpath (CPAH) Shares Extend Gain, Up 200%
December 13, 2017 10:18 AM ESTCounterpath (NASDAQ: CPAH) Shares Extend Gain, Up 200%
... MoreCounterpath (CPAH) Halted Again on LUDP
December 13, 2017 10:07 AM ESTCounterpath (NASDAQ: CPAH) Halted Again on LUDP
... MoreCounterpath (CPAH) Resumes Trading, Shares Up 90% but Off High
December 13, 2017 9:51 AM ESTCounterpath (NASDAQ: CPAH) Resumes Trading, Shares Up 90% but Off High
... MoreCounterpath (CPAH) Halted on LUDP
December 13, 2017 9:44 AM ESTCounterpath (NASDAQ: CPAH) Halted on LUDP
... MoreCounterpath (CPAH) Reports Q2 EPS of $0.01
December 13, 2017 8:16 AM ESTCounterpath (NASDAQ: CPAH) reported Q2 EPS of $0.01, versus ($0.11) reported last year. Revenue for the quarter came in at $3.4 million, versus $2.8 million reported last year.
For earnings history and earnings-related data on Counterpath (CPAH) click here.
... More